Post-authorisation Safety (PAS) Observational Cohort Study to Quantify the Incidence and Comparative Safety of Selected Cardiovascular and Cerebrovascular Events in COPD Patients Using Inhaled UMEC/VI Combination or Inhaled UMEC versus Tiotropium (Study)

    Project: Other project

    Project Details

    StatusFinished
    Effective start/end date12/7/16 → 12/6/22

    Funding

    • GlaxoSmithKline Pharmaceuticals: $15,766.15